Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 625.00 | 368.38 | 782.00 | 566.50 | 1.3804 | 2.3614 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 625.00 | 368.38 | 338.00 | 566.50 | 0.5967 | -0.1294 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 625.00 | 368.38 | 1576.00 | 566.50 | 2.7820 | 9.3919 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 625.00 | 368.38 | 778.00 | 566.50 | 1.3733 | 2.3337 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 625.00 | 368.38 | 570.00 | 566.50 | 1.0062 | 1.0199 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 625.00 | 368.38 | 580.00 | 566.50 | 1.0238 | 1.0773 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 625.00 | 368.38 | 629.00 | 566.50 | 1.1103 | 1.3672 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 625.00 | 368.38 | 913.00 | 566.50 | 1.6117 | 3.3137 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 625.00 | 368.38 | 550.00 | 566.50 | 0.9709 | 0.9070 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 625.00 | 368.38 | 227.00 | 566.50 | 0.4007 | -0.5415 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 611.00 | 566.50 | 1.0786 | 1.2590 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 570.00 | 566.50 | 1.0062 | 1.0199 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 603.00 | 566.50 | 1.0644 | 1.2116 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 523.00 | 566.50 | 0.9232 | 0.7585 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 625.00 | 368.38 | 365.00 | 566.50 | 0.6443 | -0.0147 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 625.00 | 368.38 | 615.00 | 566.50 | 1.0856 | 1.2829 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 724.00 | 566.50 | 1.2780 | 1.9690 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 625.00 | 368.38 | 249.00 | 566.50 | 0.4395 | -0.4678 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 625.00 | 368.38 | 627.00 | 566.50 | 1.1068 | 1.3551 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 625.00 | 368.38 | 834.00 | 566.50 | 1.4722 | 2.7286 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 625.00 | 368.38 | 700.00 | 566.50 | 1.2357 | 1.8121 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 625.00 | 368.38 | 617.00 | 566.50 | 1.0891 | 1.2949 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 625.00 | 368.38 | 650.00 | 566.50 | 1.1474 | 1.4958 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 625.00 | 368.38 | 794.00 | 566.50 | 1.4016 | 2.4449 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 625.00 | 368.38 | 811.00 | 566.50 | 1.4316 | 2.5644 |